Industry-university-research cooperation
Industry-university-research cooperation effectively integrates social, scientific, and technological resources and accelerates the integration of science, technology, and economy. By building a bridge of transnational education and industrial cooperation, YRPG has facilitated the global collaboration between the Group and higher education institutions, cultivating high-quality and application-oriented talents with an international market vision. For a long time, the Group has maintained close ties with universities such as Peking University, Fudan University, Lanzhou University, China Pharmaceutical University, Shenyang Pharmaceutical University, and Ocean University of China and has continuously conducted targeted training programs for international students in China in collaboration with China Pharmaceutical University. The global development of industry-education integration has far-reaching significance, which not only promotes the industrial upgrading and technological progress of the Group but also serves the sustainable development of the global economy and society. Such cooperation is irreplaceable in building an open and inclusive world and enhancing understanding among different cultures.
In recent years, YRPG's R&D centers have widely accepted the academic achievements recommended by universities and research institutes, fulfilled confidentiality obligations, and made efforts to industrialize scientific research achievements.

Prioritizing innovation and regarding R&D innovation as the strategic foundation for its sustainable development, YRPG has established a research and development team composed of nearly a thousand people, with over 50% holding master’s or doctoral degrees. Four distinct R&D bases have been set up in Shanghai, Taizhou, Nanjing, and Beijing. YRPG has obtained over 700 patent authorizations, including over 480 invention patents, and won nearly 20 awards for outstanding patents at the national, provincial, and municipal levels.
Continuously strengthening innovative R&D, YRPG focuses on the unmet clinical needs in treating diseases that severely threaten human health. Patient-centered, the Group fully uses cutting-edge technologies in global life sciences to build a future-oriented new product pipeline. It continuously promotes the launch of innovative drugs to benefit global health.
Research and Development Center
5
Research and Development Centers
800+
Research and Development Teams
50%+
The proportion of Staff with Master's or Doctor's Degrees
130+
Projects Under Research
1600+
Patent Applications
720+
Patented Inventions Granted
1200+
Applications for Invention Patents
480+
Authorized Invention Patents
Industry-university-research cooperation effectively integrates social, scientific, and technological resources and accelerates the integration of science, technology, and economy. By building a bridge of transnational education and industrial cooperation, YRPG has facilitated the global collaboration between the Group and higher education institutions, cultivating high-quality and application-oriented talents with an international market vision. For a long time, the Group has maintained close ties with universities such as Peking University, Fudan University, Lanzhou University, China Pharmaceutical University, Shenyang Pharmaceutical University, and Ocean University of China and has continuously conducted targeted training programs for international students in China in collaboration with China Pharmaceutical University. The global development of industry-education integration has far-reaching significance, which not only promotes the industrial upgrading and technological progress of the Group but also serves the sustainable development of the global economy and society. Such cooperation is irreplaceable in building an open and inclusive world and enhancing understanding among different cultures.
In recent years, YRPG's R&D centers have widely accepted the academic achievements recommended by universities and research institutes, fulfilled confidentiality obligations, and made efforts to industrialize scientific research achievements.